iDose TR for Glaucoma: A Breakthrough Advancing Eye Care Into 2026
Glaucoma is one of the leading causes of irreversible vision loss worldwide, affecting more than 3 million people in the United States, with prevalence expected to increase as the population ages, according to the National Eye Institute. Because long-term vision preservation depends on consistent intraocular pressure control, advancements in treatment are increasingly critical. One of the most significant innovations shaping [...]
















